Sitemap - 2022 - Boutique Biotech
Jounce, F-star, and Astria Therapeutics
Affimed in the spotlight (part II, ASH 2022 update)
Astria Therapeutics in the spotlight (part IV)
Medicenna & Jounce Therapeutics in the spotlight
Medicenna in the spotlight (part XI)
Milestone Pharmaceuticals in the spotlight (part IV)
Medicenna in the spotlight (part X)
Astria Therapeutics in the spotlight (part III)
Milestone Pharmaceuticals in the spotlight (part III)
Medicenna in the spotlight (part IX)
Milestone Pharmaceuticals in the spotlight (part II)
Astria Therapeutics in the spotlight (part II)
Medicenna in the spotlight (part VIII)
Milestone Pharmaceuticals and Astria Therapeutics in the spotlight
9 Meters, Jounce, and Merck updates
Boutique Biotech portfolio in the spotlight
ASCO meeting recap -- prospects for a reversal?
Medicenna in the spotlight (part VII)
Affimed in the spotlight (part X)
Genocea Biosciences in the spotlight (part II)
Affimed in the spotlight (part IX)
Affimed in the spotlight (part VIII)
Medicenna in the spotlight (part VII)
F-Star Therapeutics in the spotlight (part III)
Medicenna in the spotlight (part VI)
9 Meters Bio (NMTR) in the spotlight
Boutique Biotech speaks with Affimed management at the Leerink Healthcare Conference
Analyzing Historical Data of Precedent Rising Rate Environments